Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (43793)	1/15/1999 11:50:00 AM
From: Captain Ed	Read Replies (2) \| Respond to of 119973

GERN and others. The biotech conference you asked about on Jan 23 is in Baltomore. I am attaching a news release from yesterday about it: Outlook For Product Approvals, Scientific Breakthroughs On Tap At Bethesda Biotechnology Stocks Forum Jan. 23 BusinessWire, Thursday, January 14, 1999 at 15:06 BETHESDA, Md.--(BUSINESS WIRE)--Jan. 14, 1999--Concluding a year that saw progress on many fronts, the biotechnology industry is optimistic that 1999 will bring more product approvals, improved financial performance and significant scientific breakthroughs out of hundreds of laboratories across the land. Individual investors have an opportunity to hear the latest developments in biotechnology from a noted industry expert plus executives from several biotech companies at Informed Investors Forums in Washington D.C. and California in January and March. On Saturday morning Jan. 23 at the Bethesda Hyatt, biotechnology analyst Peter Freudenthal of BancBoston Robertson Stephens opens the Forum with an overview of the biotech industry and stocks to watch. Freudenthal is a closely-watched analyst whose knowledge of the industry is considered among the best anywhere. After Freudenthal's address, attendees will hear full presentations from executives of six biotechnology companies. Presentations are very similar to the ones given by companies to industry-focused investment banking conferences typically closed to individuals. One presenting company, Liposome (NASDAQ:LIPO) of Princeton, recently announced it has turned the corner to profitability, making it one of only a handful of profitable biotech companies. Its Abelcet product for the treatment of severe, systemic fungal infections is approved in 21 countries. Another presenting company, Gene Logic (NASDAQ:GLGC) of Rockville, Md., was recently profiled in the Washington Post. Gene Logic recently announced an important agreement with Affymetrix (NASDAQ:AFFX) to use the latter company's GeneChip probe arrays to build large, commercially available gene expression database products. A third presenter, Collateral Therapeutics (NASDAQ:CLTX) of San Diego is developing non-surgical cardiovascular gene therapy products. The other three presenting companies in Bethesda are CytRx (NASDAQ:CYTR), a leader in fighting sickle cell crisis, OSI Pharmaceuticals (NASDAQ:OSIP), a drug discovery products company, and Digene (NASDAQ:DIGE), which develops DNA and RNA tests. The Bethesda Forum runs from 8:30 a.m.-1 p.m. The cost, which includes a continental breakfast, is $30 prepaid, $40 at the door. Call Informed Investors at 800/992-4683 to register. Audio tapes will be available for $45 plus $3.95 S/H which includes all company presentations plus keynote speakers. Individual company tapes are $18. For updates on companies and speakers and the 1999 schedule, access www.informedinvestors.com. Two biotechnology Forums are scheduled for March 13 in San Diego and the San Francisco Bay Area. Among the companies that will be presenting at those Forums include Geron (NASDAQ:GERN) and Genentech (NYSE:GNE) in the Bay Area. Local company Isis Pharmaceuticals (NASDAQ:ISIP) heads up a strong group of biotechs in San Diego. On Saturday Feb. 13 in Los Angeles, a "Surgical Advances" Forum -- focusing on companies that are developing products to enhance successful surgeries -- will be highlighted. All Informed Investors biotech forums are co-sponsored by BioSpace.com, recently named the best biotechnology website. Since 1993, Informed Investors has hosted scores of quality companies and industry experts at its Forums. In 1998, the company hosted 20 Forums. CONTACT: Informed Investors Steve Chanecka/Tim Quast, 916/448-8222 or 800/992-4683 KEYWORD: CALIFORNIA MARYLAND INDUSTRY KEYWORD: BIOTECHNOLOGY Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com